Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.4	40.24	53.5	102.53	160.92	25.44
Short-Term Investments	135.56	145.19	23.47	-	-	-
Cash & Short-Term Investments	165.96	185.43	76.97	102.53	160.92	25.44
Cash Growth	167.10%	140.91%	-24.93%	-36.29%	532.51%	1259.08%
Accounts Receivable	-	-	1.03	0.53	0.47	-
Other Receivables	0.23	1.05	0.82	-	-	-
Receivables	0.23	1.05	1.86	0.53	0.47	-
Prepaid Expenses	3.81	2.16	0.99	1.62	0.9	0.67
Total Current Assets	170	188.63	79.82	104.68	162.29	26.11
Property, Plant & Equipment	20.79	20.43	24.64	27.62	4.08	2.39
Long-Term Deferred Charges	-	-	-	-	3.17	0.59
Other Long-Term Assets	0.47	0.53	0.65	0.76	0.39	0.14
Total Assets	191.26	209.58	105.11	133.05	169.93	29.23
Accounts Payable	2.04	1.12	0.61	1.1	1.44	2.15
Accrued Expenses	6.38	7.39	8.02	10.15	10.13	3.16
Current Portion of Leases	3.72	3.74	3.6	3.49	0.43	0.46
Current Unearned Revenue	-	-	-	10.89	7.3	-
Total Current Liabilities	12.2	12.25	12.23	25.63	19.31	5.76
Long-Term Leases	10.28	10.61	13.32	15.96	1.31	1.66
Long-Term Unearned Revenue	-	-	-	15.64	21.68	-
Other Long-Term Liabilities	-	0.07	25.17	0.12	0.08	5.31
Total Liabilities	22.48	22.94	50.72	57.34	42.37	12.73
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	435.78	433.45	18.99	11.9	4.95	0.41
Retained Earnings	-267	-246.68	-181.31	-152.59	-93.8	-21.98
Comprehensive Income & Other	-	-0.13	0.31	-	-	-
Total Common Equity	168.78	186.64	-162.02	-140.7	-88.86	-21.57
Shareholders' Equity	168.78	186.64	54.4	75.72	127.56	16.5
Total Liabilities & Equity	191.26	209.58	105.11	133.05	169.93	29.23
Total Debt	14	14.35	16.91	19.45	1.74	2.12
Net Cash (Debt)	151.97	171.07	60.06	83.08	159.18	23.33
Net Cash Growth	231.26%	184.84%	-27.71%	-47.81%	582.42%	-
Net Cash Per Share	8.87	15.19	74.82	108.36	232.10	36.94
Filing Date Shares Outstanding	24.36	24.36	0.81	0.77	0.71	0.73
Total Common Shares Outstanding	24.36	24.29	0.81	0.77	0.71	0.73
Working Capital	157.8	176.38	67.59	79.05	142.98	20.34
Book Value Per Share	6.93	7.68	-200.07	-183.50	-124.96	-29.71
Tangible Book Value	168.78	186.64	-162.02	-140.7	-88.86	-21.57
Tangible Book Value Per Share	6.93	7.68	-200.07	-183.50	-124.96	-29.71
Machinery	13.12	11.88	11.24	-	2.78	0.53
Leasehold Improvements	0.47	0.41	0.39	-	0.04	0.04

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q